Cellectar Biosciences
CLRB
12 hedge funds and large institutions have $426K invested in Cellectar Biosciences in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
16% less capital invested
Capital invested by funds: $505K → $426K (-$78.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$98.3K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$73.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$58.3K |
| 4 |
IGGA
Iron Gate Global Advisors
Nsl,
Utah
|
+$15.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$18K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$3.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $153K | +$3.07K | +1 | +1% |
|
|
VF
2
Virtu Financial
New York
| $59K | +$98.3K | +32 | New |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $44K | +$73.7K | +24 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $35K | +$58.3K | +19 | New |
|
5
State Street
Boston,
Massachusetts
| $34K | – | – | – |
|
|
TSS
6
Two Sigma Securities
New York
| $20K | -$3.07K | -1 | -8% |
|
|
AIC
7
AWM Investment Company
New York
| $19K | – | – | – |
|
|
IGGA
8
Iron Gate Global Advisors
Nsl,
Utah
| $19K | +$15.4K | +5 | +100% |
|
9
Northern Trust
Chicago,
Illinois
| $18K | – | – | – |
|
10
US Bancorp
Minneapolis,
Minnesota
| $18K | – | – | – |
|
11
Morgan Stanley
New York
| $3K | – | – | – |
|
|
SIM
12
Sonora Investment Management
Tucson,
Arizona
| $3K | – | – | – |
|
|
WAM
13
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| $1K | – | – | – |
|
|
APA
14
American Portfolios Advisors
Holbrook,
New York
| $1 | – | – | – |
|
|
15
Creative Planning
Overland Park,
Kansas
| – | -$18K | -5 | Closed |
|
CLRB Hedge Fund Activity: Q2 2018 in Review
12 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q2 2018, worth a combined $426K — down 16% from $505K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CLRB positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $98.3K. The largest seller was Creative Planning, exiting entirely with an estimated $18K sold.
- 12 institutional investors held Cellectar Biosciences (CLRB) as of Q2 2018, up from 10 in Q1 2018.
- Funds reported $426K of Cellectar Biosciences stock for Q2 2018, down 16% quarter-over-quarter.
- 3 funds opened new Cellectar Biosciences positions in Q2 2018 and 1 closed out, a net change of +2 holders.
- The largest Cellectar Biosciences buyer in Q2 2018 was Virtu Financial, an estimated $98.3K added.
- The largest Cellectar Biosciences seller in Q2 2018 was Creative Planning, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2018.